| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | APTALOGIC, INC. | 1111 HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R43CK000697 | PA21259, SBIR, Phase I, Aptamer-upconverting nanocrystal conjugate lateral flow assay for immediate Ebola virus detection | 02 | 1 | CDC | 10/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | APTALOGIC, INC. | 1111 HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R43CK000697 | PA21259, SBIR, Phase I, Aptamer-upconverting nanocrystal conjugate lateral flow assay for immediate Ebola virus detection | 01 | 1 | CDC | 9/13/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $264,271 ) |
| | 2023 | 2023 | APTALOGIC, INC. | 1111 HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R43CK000697 | PA21259, SBIR, Phase I, Aptamer-upconverting nanocrystal conjugate lateral flow assay for immediate Ebola virus detection | 00 | 1 | CDC | 8/23/2023 | $264,271 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2019 | APTALOGIC, INC. | 1111 N HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R41AI147853 | An aptasensor to distinguish Dengue virus from Zika virus | 000 | 1 | NIH | 4/12/2022 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $150,000 ) |
| | 2019 | 2019 | APTALOGIC, INC. | 1111 N HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R41AI147853 | An aptasensor to distinguish Dengue virus from Zika virus | 000 | 1 | NIH | 8/1/2019 | $150,000 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | APTALOGIC, INC. | 1111 N HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R43AI118139 | Detecting Ebola Virus Infections | 000 | 2 | NIH | 8/21/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $306,409 ) |
| | 2017 | 2017 | APTALOGIC, INC. | 1111 N HYLAND AVE | AMES | IA | 50014-4007 | STORY | USA | R44DK098031 | Early diagnosis of acute kidney injury by aptasensors | 000 | 4 | NIH | 8/18/2017 | $306,409 |
|
| Issue Date FY: 2016 ( Subtotal = $704,278 ) |
| | 2016 | 2016 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R43AI118139 | Detecting Ebola Virus Infections | 000 | 2 | NIH | 8/4/2016 | $330,352 |
| | 2016 | 2016 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R44DK098031 | Early diagnosis of acute kidney injury by aptasensors | 000 | 3 | NIH | 8/26/2016 | $373,926 |
|
| Issue Date FY: 2015 ( Subtotal = $662,024 ) |
| | 2015 | 2015 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43AI118139 | Detecting Ebola Virus Infections | 001 | 1 | NIH | 2/20/2015 | $0 |
| | 2015 | 2015 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R43AI118139 | Detecting Ebola Virus Infections | 000 | 1 | NIH | 2/11/2015 | $352,405 |
| | 2015 | 2015 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R44DK098031 | Early diagnosis of acute kidney injury by aptasensors | 000 | 2 | NIH | 9/14/2015 | $309,619 |
|
| Issue Date FY: 2013 ( Subtotal = $150,501 ) |
| | 2013 | 2013 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43DK098031 | EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY BY APTASENSORS | 001 | 1 | NIH | 8/27/2013 | $0 |
| | 2013 | 2013 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R43DK098031 | EARLY DIAGNOSIS OF ACUTE KIDNEY INJURY BY APTASENSORS | 000 | 1 | NIH | 8/14/2013 | $150,501 |
|
| Issue Date FY: 2011 ( Subtotal = $0 ) |
| | 2011 | 2009 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 5 | NIH | 8/8/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $0 ) |
| | 2010 | 2009 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 5 | NIH | 10/15/2009 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $440,517 ) |
| | 2009 | 2009 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014-4007 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 5 | NIH | 8/31/2009 | $440,517 |
| | 2009 | 2009 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 001 | 5 | NIH | 10/15/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $422,547 ) |
| | 2008 | 2008 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 4 | NIH | 8/8/2008 | $422,547 |
|
| Issue Date FY: 2007 ( Subtotal = $247,007 ) |
| | 2007 | 2007 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 3 | NIH | 8/14/2007 | $247,007 |
|
| Issue Date FY: 2006 ( Subtotal = $239,864 ) |
| | 2006 | 2006 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 2 | NIH | 8/25/2006 | $239,864 |
|
| Issue Date FY: 2004 ( Subtotal = $405,613 ) |
| | 2004 | 2004 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R42CA110222 | APTAMERS FOR IMAGING AND THERAPY | 000 | 1 | NIH | 9/10/2004 | $100,000 |
| | 2004 | 2004 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43CA102816 | ANTI-PSCA ALLOSTERIC CLAMPS | 000 | 2 | NIH | 7/16/2004 | $198,613 |
| | 2004 | 2004 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43CA100977 | SMART PROBES FOR IMAGING CANCER | 000 | 2 | NIH | 4/30/2004 | $107,000 |
|
| Issue Date FY: 2003 ( Subtotal = $303,406 ) |
| | 2003 | 2003 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43CA102816 | ANTI-PSCA ALLOSTERIC CLAMPS | 000 | 1 | NIH | 7/9/2003 | $196,406 |
| | 2003 | 2003 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R43CA100977 | SMART PROBES FOR IMAGING CANCER | 000 | 1 | NIH | | $107,000 |
|
| Issue Date FY: 2001 ( Subtotal = $106,257 ) |
| | 2001 | 2001 | MOLECULAR EXPRESS INC | 1111 NORTH HYLAND AVENUE | AMES | IA | 50014 | STORY | USA | R41AI049689 | TARGETED APTAMER PROBES FOR NUCLEIC ACID DETECTION | 000 | 1 | NIH | 9/7/2001 | $106,257 |
|
|
